A study of Interleukin 6 as a predictive biomarker for development of Nonalcholic steatohepatitis in patients with Nonalcholic fatty liver disease

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide, with a prevalence of 15%-30% in Western populations. Non-alcoholic fatty liver disease (NAFLD) has emerged as the most important cause of chronic liver disease related to the increase in incidence of obesity and diabetes mellitus type II in the population.